Fomenko G V, Lipitskaia I Ia, Tuminen T, Babaeva N I, Arabidze G G, Titov V N
Ter Arkh. 1992;64(4):30-3.
N-acetyl-beta-glucosaminidase (NAG) activity, the concentrations of microalbumin (MA) and B2-microglobulin (B2-MG) were measured in urine of 50 healthy subjects and 200 patients suffering from arterial hypertension (AH) with preserved renal function, including patients with essential hypertension (EH), stages I and II, chronic pyelonephritis (CPN), chronic glomerulonephritis (CGN) and vasorenal hypertension (VRH). The healthy subjects, the patients with stage II EH, and those with secondary forms of AH demonstrated significant differences in NAG activity in urine. A positive correlation (r = +0.53; p < 0.03) was discovered between systolic AP and NAG activity in urine of EH patients. The concentration of MA in urine of CGN and VRH patients was significantly higher than that in the healthy subjects, EH and CPN patients. The patients with CPN and VRH showed significantly higher levels of B2-MG in urine.
对50名健康受试者以及200名肾功能正常的动脉高血压(AH)患者的尿液进行检测,测定其中N - 乙酰 - β - 氨基葡萄糖苷酶(NAG)活性、微量白蛋白(MA)浓度和β2 - 微球蛋白(B2 - MG)浓度。这些AH患者包括I期和II期原发性高血压(EH)患者、慢性肾盂肾炎(CPN)患者、慢性肾小球肾炎(CGN)患者以及肾血管性高血压(VRH)患者。健康受试者、II期EH患者以及继发性AH患者的尿NAG活性存在显著差异。在EH患者尿液中,收缩压与NAG活性之间发现正相关(r = +0.53;p < 0.03)。CGN和VRH患者尿液中MA浓度显著高于健康受试者、EH患者和CPN患者。CPN和VRH患者尿液中B2 - MG水平显著更高。